Stock listing
Imugene Ltd
Selected listing: IUGNF · OTC · USD · US
Imugene Ltd (OTC:IUGNF), Health Technology. Latest release Oct 4, 2026: azer-cel BTKi Cohort Reports new Complete & Partial Response.
- Ticker
- OTC:IUGNF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
About Imugene Ltd
The company focuses on developing innovative immunotherapies for cancer treatment. Imugene aims to enhance patient outcomes through its research and development efforts in the biotechnology sector.
Latest news from Imugene Ltd
azer-cel BTKi Cohort Reports new Complete & Partial Response
October 4, 2026
Third response in concurrent BTKi Cohort of azer-cel Trial
July 26, 2026
$11.1 Million Placement Completed to Advance azer-cel
July 6, 2026
New Complete Response in the Concurrent BTKi azer-cel Cohort
June 30, 2026
First Complete Response in Concurrent BTKi azer-cel Cohort
June 29, 2026